19402-33-6

Basic information

• Product Name: 1-Phenanthrenecarboxylic acid,1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro- 1,4a-dimethyl-7-(1-methylethylidene)-,(1R,- 4aS,10aR)-
• CAS NO: 19402-33-6
• Mol File: 19402-33-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-Phenanthrenecarboxylic acid,1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro- 1,4a-dimethyl-7-(1-methylethylidene)-,(1R,- 4aS,10aR)- (CAS DataBase Reference)
• NIST Chemistry Reference: 1-Phenanthrenecarboxylic acid,1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro- 1,4a-dimethyl-7-(1-methylethylidene)-,(1R,- 4aS,10aR)- (19402-33-6)
• EPA Substance Registry System: 1-Phenanthrenecarboxylic acid,1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro- 1,4a-dimethyl-7-(1-methylethylidene)-,(1R,- 4aS,10aR)- (19402-33-6)

Safety Data

• Hazardous Substances Data: 19402-33-6(Hazardous Substances Data)

Usage

Molecular Weight

350.52 g/mol
The molecular weight of the compound is 350.52 g/mol, which is the sum of the atomic weights of all the atoms in the molecule.

Classification

Carboxylic Acid
The compound is classified as a carboxylic acid due to the presence of a carboxyl functional group (-COOH).

Core Structure

Phenanthrene Backbone
The core structure of the compound is based on a phenanthrene backbone, which is a tricyclic aromatic hydrocarbon consisting of three fused six-membered rings.

Dodecahydro Ring System

1,4a-Dimethyl-7-(1-methylethylidene)
The compound features a dodecahydro (12-hydrogen) ring system, with a 1,4a-dimethyl and 7-(1-methylethylidene) substituents.

Stereochemistry

(1R, 4aS, 10aR)
The compound has a specific stereochemistry, with the chiral centers labeled as (1R, 4aS, 10aR), indicating the spatial arrangement of the atoms in the molecule.

Applications

Pharmaceuticals, Organic Synthesis, Laboratory Research

Structural Complexity

Intriguing Subject for Study and Exploration
The complex and specific structure of the compound makes it an intriguing subject for further study and exploration in the fields of chemistry and material science.

Upstream product

• 514-10-3 abietic acid 
• 22628-82-6 8.15-dibromo-8ξ.13ξH-abietanoic acid-(18) 
• 141-52-6 sodium ethanolate 
• 19402-34-7 methyl abieta-8,13⁽¹⁵⁾-dien-18-oate 

Downstream Products

• 185379-98-0 (1R,4aS,10aR)-1,4a-Dimethyl-7-(2,2,2-triphenyl-acetoxy)-1,2,3,4,4a,5,6,9,10,10a-decahydro-phenanthrene-1-carboxylic acid methyl ester 
• 185379-95-7 (1R,4aS,10aR)-1,4a-Dimethyl-7-triphenylsilanyloxy-1,2,3,4,4a,5,6,9,10,10a-decahydro-phenanthrene-1-carboxylic acid methyl ester 
• 65894-41-9 abieta-8,11,13-triene-15,18-diol 
• 19402-34-7 methyl abieta-8,13⁽¹⁵⁾-dien-18-oate 

Relevant articles and documents

Preparation method of 15-hydroxyl dehydrogenated abietane and intermediate of 15-hydroxyl dehydrogenated abietane

The invention discloses a preparation method of 15-hydroxyl dehydrogenated abietane and an intermediate of 15-hydroxyl dehydrogenated abietane. The preparation method comprises the following steps: converting a compound 1 into a compound 5, and converting the compound 5 into a compound 8. According to the method for preparing the compound 8, the problem that a product cannot be separated out of a glacial acetic acid solution because reaction impurities are remarkably increased when the feeding quantity is increased at the hydrogen bromide addition step in the existing synthesis route is solved through continuous screening of a process route. Furthermore, the method provided by the invention is high in yield at each step, easy to amplify and suitable for industrialized large-scale production. (The formula is as shown in the description.).

Synthesis and biological evaluation of abietic acid derivatives

A series of C18-oxygenated derivatives of abietic acid were synthesized and evaluated for their cytotoxic, antimycotic, and antiviral activities. In general, the introduction of an aldehyde group at C18 did improve the resultant bioactivity, while the presence of an acid or alcohol led to less active compounds.